Dr. Hervé Eloi Dominique Brailly is a Chairman at Kalsiom SAS, a Chairman at NH Theraguix SAS, an Independent Director at Deinove SA, a Treasurer at EuroBioMed, a Chairman-Supervisory Board at Innate Pharma SA, a Chairman at Kervrant Biotech, a Chairman at Polytech Marseille, a Chairman at Université d'Aix-Marseille, a Partner at Asajes Ventures Ltd. and a Treasurer at BioCuster.
He is on the Board of Directors at Deinove SA and Swenson Global SA. Dr. Brailly was previously employed as a Member by Chambre de Commerce et d'Industrie Marseille Provence, a Member-Supervisory Board by INSERM Transfert SA, a Member-Development Council by Marseille Provence Métropole, and a Member-Executive Board by Platine Pharma Services SAS.
He also served on the board at France Biotech Association and Innate Pharma, Inc.
He received his undergraduate degree from École Nationale Supérieure des Mines de Paris.